scispace - formally typeset
V

Veronica Papa

Researcher at University of Naples Federico II

Publications -  37
Citations -  1412

Veronica Papa is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Protein kinase B & Medicine. The author has an hindex of 15, co-authored 30 publications receiving 1241 citations. Previous affiliations of Veronica Papa include University of Cassino & University of Bologna.

Papers
More filters
Journal ArticleDOI

MMP Activity in the Hybrid Layer Detected with in situ Zymography

TL;DR: Investigating the HL gelatinolytic activity by in situ zymography and functional enzyme activity assay demonstrates, for the first time, intrinsic MMP activity in the HL, and intense activation of matrix-bound M MP activity with both etching and adhesive application.
Journal ArticleDOI

Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts

TL;DR: Evidence is presented that MRP1, but not P-gp, expression is under the control of the PI3K/Akt axis in AML blasts, and data suggest that PI3k/AKT activation may lead to the development of chemoresistance inAML blasts through a mechanism involving a p53-dependent suppression of MRP 1 expression.
Journal ArticleDOI

Teaching anatomy in the XXI century: New aspects and pitfalls

TL;DR: Traditional anatomy education based on topographical structural anatomy taught in lectures and gross dissection classes has been replaced by a multiple range of study modules, including problem-based learning, plastic models or computer-assisted learning, and curricula integration.
Journal ArticleDOI

Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells

TL;DR: The findings indicate that perifosine, either alone or in combination with existing drugs, might be a promising therapeutic agent for the treatment of those AML cases characterized by upregulation of the PI3K–Akt survival pathway.
Journal ArticleDOI

Synergistic Proapoptotic Activity of Recombinant TRAIL Plus the Akt Inhibitor Perifosine in Acute Myelogenous Leukemia Cells

TL;DR: The combination of perifosine and TRAIL might offer a novel therapeutic strategy for AML, and the combined treatment negatively affected the clonogenic activity of CD34(+) cells from patients with AML.